HK Stock Movement | CANBRIDGE-B (01228) Surges Nearly 18% Intraday as Three Rare Disease Products Included in 2026 Beijing Inclusive Health Insurance
Stock News
Nov 17, 2025
CANBRIDGE-B (01228) saw an intraday surge of nearly 18%, and as of the latest update, the stock rose 11.76% to HKD 2.09, with a turnover of HKD 10.22 million. The rally follows the recent announcement of the 2026 Beijing Inclusive Health Insurance coverage details, which included all three of CANBRIDGE's rare disease products. Notably, Gornin made its debut in the insurance program.
Gornin received market approval on May 13 this year. On July 2, the first prescription was issued at Xinhua Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, marking its official entry into clinical use. This development is expected to significantly improve drug accessibility for domestic patients.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.